Chronic Viral and Inflammatory Cardiomyopathy, 2006 Ernst Schering Foundation Symposium Proceedings Series, Vol. 55

Cytokines and cytokine receptors remain an area of great interest for the development of targeted therapies for cutaneous inflammatory diseases. Anti-TNF therapeutics have proven to be effective in the treatment of psoriasis, and clinical investigations have now begun for other cytokine-directed therapies, such as those targeting IFN-g, IL-12p40, and IL-18. In addition to therapeutics that target cytokines directly, strategies that target cytokine signaling pathways are in development. This book summarizes the findings of the 56th International Workshop of the Ernst Schering Research Foundation that focused on Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases.

Chronic Viral and Inflammatory Cardiomyopathy.- Overview on Chronic Viral Cardiomyopathy/Chronic Myocarditis.- Unsolved Medical Issues and New Targets for Further Research in Viral Myocarditis and Dilated Cardiomyopathy.- Viruses.- Frontiers in Viral Diagnostics.- Invited for Debate: Is Virus Persistence a Determinant for Disease Progression?.- Parvovirus B19: The Causative Agent of Dilated Cardiomyopathy or a Harmless Passenger of the Human Myocard?.- Parvovirus B19: A New Emerging Pathogenic Agent of Inflammatory Cardiomyopathy.- Role of Hepatitis C Virus in Cardiomyopathies.- Immunity and Autoimmunity.- Recent Insights into the Role of Host Innate and Acquired Immunity Responses.- The Significance of Autoimmunity in Myocarditis.- The Roles of Immunity and Autoimmunity in Chronic Heart Failure.- Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy.- Cardiac Remodeling.- Inflammation and Cardiac Remodeling During Viral Myocarditis.- Inflammatory Cardiomyopathy: There Is a Specific Matrix Destruction in the Course of the Disease.- Invited for Debate: Is There a Virus-Specific Matrix Destruction in the Course of Disease in Dilated Cardiomyopathy?.- Diagnosis and Treatment.- New Non-invasive Approaches for the Diagnosis of Cardiomyopathy: Magnetic Resonance Imaging.- New Therapeutics Targets in Chronic Viral Cardiomyopathy.- Myocarditis and Inflammatory Cardiomyopathy: Histomorphological Diagnosis.- Anti-viral Treatment in Patients with Virus-Induced Cardiomyopathy.- Immunosuppressive Treatment of Chronic Non-viral Myocarditis.- Immunoadsorption in Dilated Cardiomyopathy.

Latest insights in the research, advancing and understanding of what causes chronic viral and inflammatory cardiomayopathy, how we can develop better therapies, whether the disease can be prevented Includes supplementary material: sn.pub/extras